(Q40913079)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

review article

1 reference

title

Newer concepts in the medical management of patients with congestive heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

main subject

congestive heart failure

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

author name string

B R Chaitman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

publication date

1 May 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

13 October 2019

page(s)

380-390

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8504571%20AND%20SRC:MED&resulttype=core&format=json

Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension.

13 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Comparisons in vitro, ex vivo, and in vivo of the actions of seven structurally diverse inhibitors of angiotensin converting enzyme (ACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Digoxin. A neurohormonal modulator in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Sympathoinhibitory responses to digitalis glycosides in heart failure patients. Direct evidence from sympathetic neural recordings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Digitalis-induced augmentation of cardiopulmonary baroreflex control of forearm vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Carotid sinus baroreceptor sensitivity in experimental heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Hemorrhagic complications of long-term anticoagulant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

Endothelium-dependent vasodilation is attenuated in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

The Natural History of Congestive Heart Failure: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Marked spontaneous improvement in ejection fraction in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

An overview of contemporary etiologies of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Significance of Diastolic Dysfunction of the Heart

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Changes in diastolic function--difficult to measure, harder to interpret

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Mechanisms in heart failure and the role of angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Vasodilator therapy for heart failure. The influence of impedance on left ventricular performance

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Potential role of the tissue renin-angiotensin system in the pathophysiology of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Determinants of clinical response and survival in patients with congestive heart failure treated with captopril

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Local generation and release of angiotensin II in peripheral vascular tissue

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

The mas oncogene encodes an angiotensin receptor

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Left ventricular remodeling after acute myocardial infarction: Clinical course and beneficial effects of angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Importance of venodilatation in prevention of left ventricular dilatation after chronic large myocardial infarction in rats: a comparison of captopril and hydralazine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Renin- and non-renin–mediated antihypertensive actions of converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Comparison of captopril and enalapril in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Thiazides with loop diuretics for severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Heart failure in outpatients: a randomized trial of digoxin versus placebo

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

A controlled trial of digoxin in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Acetylstrophanthidin-induced reflex inhibition of canine renal sympathetic nerve activity mediated by cardiac receptors with vagal afferents

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Digitalis and baroreceptor reflexes in man

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Nitrates for congestive heart failure.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Prevention and reversal of nitrate tolerance in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Heart Failure in 1991

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Future perspectives in the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Development of arrhythmias in the patient with congestive heart failure: pathophysiology, prevalence and prognosis

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Congestive heart failure and arrhythmias: an overview

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

https://api.crossref.org/works/10.1002%2FCLC.4960160504

1 reference

7 January 2021

Clinical, haemodynamic, and antiarrhythmic effects of long term treatment with amiodarone of patients in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Ventricular arrhythmias in dilated cardiomyopathy: Efficacy of amiodarone

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Cardiovascular injury induced by sympathetic catecholamines

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: assessment by 2-dimensional echocardiography

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Predictors of thromboembolism in atrial fibrillation: I. Clinical features of patients at risk. The Stroke Prevention in Atrial Fibrillation Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Adaptive changes in the periphery and their therapeutic consequences

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Exercise training in patients with severe left ventricular dysfunction. Hemodynamic and metabolic effects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Controlled trial of enalapril in congestive cardiac failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021

Effectiveness of converting enzyme inhibition (enalapril) for mild congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960160504

7 January 2021